Predictive factors for the development of proteinuria in cancer patients treated with bevacizumab, ramucirumab, and aflibercept: a single-institution retrospective analysis
Yuko Kanbayashi
◽
Takeshi Ishikawa
◽
Yusuke Tabuchi
◽
Koichi Sakaguchi
◽
Yoshimi Ouchi
◽
...
Pinar Gursoy
◽
Burcu Çakar
◽
Deniz Nart
◽
Erdem Göker
2017 ◽
Vol 8
(31)
◽
pp. 51840-51847
◽
Xiaotian Han
◽
Hao Wen
◽
Xingzhu Ju
◽
Xiaojun Chen
◽
Guihao Ke
◽
...
2013 ◽
Vol 139
(2)
◽
pp. 497-506
◽
Carmen A. Perez
◽
Zachary S. Zumsteg
◽
Gaorav Gupta
◽
Monica Morrow
◽
Brittany Arnold
◽
...
2005 ◽
Vol 23
(16_suppl)
◽
pp. 7342-7342
C. J. Andrade
◽
C. G. Ferreira
◽
J. L. Pereira
◽
A. L. Porto
◽
E. D. Freitas
◽
...
2016 ◽
Vol 4
(3)
◽
pp. 456-460
◽
LI MA
◽
YUEPING LIU
◽
JIANXIN WANG
◽
YUAN CHANG
◽
LONG YU
◽
...
2005 ◽
Vol 49
◽
pp. S206-S207
M. Zukin
◽
C. Ferreira
◽
P. Hermont
◽
R. Dienstmann
◽
G. Cunha
◽
...
2017 ◽
Vol 15
(5)
◽
pp. e801-e807
◽
Diletta Bianchini
◽
David Lorente
◽
Pasquale Rescigno
◽
Zafeiris Zafeiriou
◽
Elena Psychopaida
◽
...
Elżbieta Nowara
◽
Eliza Działach
◽
Mateusz Grajek
◽
Zofia Kolosza
◽
Joanna Huszno
A Perelló
◽
J Alarcon
◽
C Garcias
◽
J Duran
◽
B Colom
◽
...
2018 ◽
Vol 10
◽
pp. 29-35
◽
Amarnath Challapalli
◽
Steve M. Edwards
◽
Paul Abel
◽
Stephen A. Mangar
Close
Export Citation Format
Close
Share Document
Close